Literature DB >> 27597128

Short Hairpin RNA Knockdown of Connective Tissue Growth Factor by Ultrasound-Targeted Microbubble Destruction Improves Renal Fibrosis.

Shuping Wei1, Chaoli Xu1, Joshua J Rychak2, Alice Luong2, Yu Sun3, Zhijian Yang3, Mingxia Li1, Chunrui Liu1, Ninghua Fu1, Bin Yang4.   

Abstract

The purpose of this study was to evaluate whether ultrasound-targeted microbubble destruction transfer of interfering RNA against connective tissue growth factor (CTGF) in the kidney would ameliorate renal fibrosis in vivo. A short hairpin RNA (shRNA) targeting CTGF was cloned into a tool plasmid and loaded onto the surface of a cationic microbubble product. A unilateral ureteral obstruction (UUO) model in mice was used to evaluate the effect of CTGF knockdown. Mice were administered the plasmid-carrying microbubble intravenously, and ultrasound was applied locally to the obstructed kidney. Mice undergoing a sham UUO surgery and untreated UUO mice were used as disease controls, and mice administered plasmid alone, plasmid with ultrasound treatment and microbubbles and plasmid without ultrasound were used as treatment controls. Mice were treated once and then evaluated at day 14. CTGF in the kidney was measured by quantitative reverse transcription polymerase chain reaction and Western blot. Expression of CTGF, transforming growth factor β1, α smooth muscle actin and type I collagen in the obstructed kidney was evaluated by immunohistochemistry. The cohort treated with plasmid-carrying microbubbles and ultrasound exhibited reduced mRNA and protein expression of CTGF (p < 0.01). Furthermore, CTGF gene silencing decreased the interstitial deposition of transforming growth factor β1, α smooth muscle actin and type I collagen as assessed in immunohistochemistry, as well as reduced renal fibrosis in pathologic alterations (p < 0.01). No significant changes in target mRNA, protein expression or disease pathology were observed in the control cohorts. A single treatment of ultrasound-targeted microbubble destruction is able to deliver sufficient shRNA to inhibit the expression of CTGF and provide a meaningful reduction in disease severity. This technique may be a potential therapy for treatment of renal fibrosis.
Copyright © 2016 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cationic microbubbles; Connective tissue growth factor; Gene delivery; RNA interfering; Renal fibrosis; Short hairpin RNA; Sonoporation; Transforming growth factor-β; Ultrasound-targeted microbubble destruction; Unilateral ureteral obstruction

Mesh:

Substances:

Year:  2016        PMID: 27597128     DOI: 10.1016/j.ultrasmedbio.2016.07.022

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  6 in total

Review 1.  New Ultrasound Techniques Promise Further Advances in AKI and CKD.

Authors:  Travis D Hull; Anupam Agarwal; Kenneth Hoyt
Journal:  J Am Soc Nephrol       Date:  2017-09-18       Impact factor: 10.121

2.  Ultrasound for the treatment of acute kidney injury and other inflammatory conditions: a promising path toward noninvasive neuroimmune regulation.

Authors:  Jieru Cai; William T Nash; Mark D Okusa
Journal:  Am J Physiol Renal Physiol       Date:  2020-06-08

Review 3.  Nano-sized carriers in gene therapy for renal fibrosis in vivo.

Authors:  Haruhisa Miyazawa; Keiji Hirai; Susumu Ookawara; Kenichi Ishibashi; Yoshiyuki Morishita
Journal:  Nano Rev Exp       Date:  2017-06-13

4.  Ultrasound Assisted a Peroxisome Proliferator-Activated Receptor (PPAR)γ Agonist-Loaded Nanoparticle-Microbubble Complex to Attenuate Renal Interstitial Fibrosis.

Authors:  Shuping Wei; Chaoli Xu; Yidan Zhang; Zhongqing Shi; Min Wu; Bin Yang
Journal:  Int J Nanomedicine       Date:  2020-10-02

Review 5.  The promising shadow of microbubble over medical sciences: from fighting wide scope of prevalence disease to cancer eradication.

Authors:  Ali Jangjou; Amir Hossein Meisami; Kazem Jamali; Mohammad Hadi Niakan; Milad Abbasi; Mostafa Shafiee; Majid Salehi; Ahmad Hosseinzadeh; Ali Mohammad Amani; Ahmad Vaez
Journal:  J Biomed Sci       Date:  2021-06-21       Impact factor: 8.410

6.  CTGF Contributes to the Development of Posterior Capsule Opacification: an in vitro and in vivo study.

Authors:  Bo Ma; Ruihua Jing; Jie Liu; Lan Yang; Jingming Li; Li Qin; Lijun Cui; Cheng Pei
Journal:  Int J Biol Sci       Date:  2018-03-11       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.